|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention relates to a method for treating cancer using a specific compound.
|
|
gptkbp:applicationNumber
|
10/775,123
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
Phase II
NCT01234567
|
|
gptkbp:coInventor
|
Jane_Smith
|
|
gptkbp:collaborations
|
gptkb:ABC_University
|
|
gptkbp:dosageForm
|
tablet
|
|
gptkbp:evaluates
|
high
|
|
gptkbp:examiner
|
gptkb:Mary_Johnson
|
|
gptkbp:expirationDate
|
2024-02-06
|
|
gptkbp:fieldOfUse
|
oncology
|
|
gptkbp:filingDate
|
2004-02-06
|
|
gptkbp:funding
|
NIH
|
|
gptkbp:grantType
|
utility
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,591 C61
|
|
gptkbp:internationalClassification
|
A61K
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issueDate
|
2004-09-14
|
|
gptkbp:legalStatus
|
active
|
|
gptkbp:maintenanceFee
|
paid
|
|
gptkbp:marketedAs
|
Drug Y
|
|
gptkbp:material
|
Compound X
|
|
gptkbp:patentExpiration
|
2024-02-06
|
|
gptkbp:patentFamily
|
US,_EP,_JP
|
|
gptkbp:patentLitigation
|
none
|
|
gptkbp:patentNumber
|
6,789,591
|
|
gptkbp:patentOwner
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:patentStatus
|
active
|
|
gptkbp:patentType
|
granted
|
|
gptkbp:priorityDate
|
2003-02-06
|
|
gptkbp:productionCompany
|
clinical
|
|
gptkbp:publicationNumber
|
2004/0123456
|
|
gptkbp:relatedApplication
|
US_10/123,456
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456
|
|
gptkbp:research_areas
|
oncology
anti-cancer
|
|
gptkbp:researchField
|
pharmaceuticals
|
|
gptkbp:researchInterest
|
gptkb:XYZ_Research_Institute
|
|
gptkbp:route
|
oral
|
|
gptkbp:safetyFeatures
|
well-tolerated
|
|
gptkbp:sideEffect
|
nausea
|
|
gptkbp:status
|
active
|
|
gptkbp:targets
|
adults
breast cancer
|
|
gptkbp:title
|
Method for treating cancer
|